Good manufacturing practices for pharmaceuticals: A plan for total quality control
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
New York
Dekker
1975
|
Schriftenreihe: | Drugs and the pharmaceutical sciences.
2. |
Schlagworte: | |
Beschreibung: | X, 167 S. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV007417465 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 930421s1975 |||| 00||| eng d | ||
035 | |a (OCoLC)1959391 | ||
035 | |a (DE-599)BVBBV007417465 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-188 | ||
050 | 0 | |a QV771 W732g 1975 | |
050 | 0 | |a RS189 | |
082 | 0 | |a 615/.19 | |
084 | |a VX 5500 |0 (DE-625)147800:253 |2 rvk | ||
100 | 1 | |a Willig, Sidney H. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Good manufacturing practices for pharmaceuticals |b A plan for total quality control |c Sidney H. Willig ; Murray M. Tuckerman ; William S. Hitchings* |
264 | 1 | |a New York |b Dekker |c 1975 | |
300 | |a X, 167 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Drugs and the pharmaceutical sciences. |v 2. | |
650 | 4 | |a Industrie pharmaceutique - Qualité - Contrôle | |
650 | 4 | |a Médicaments - Normes - États-Unis | |
650 | 4 | |a Drug Industry |x standards |z United States | |
650 | 4 | |a Drugs |x Standards |z United States | |
650 | 4 | |a Legislation, Drug |z United States | |
650 | 4 | |a Pharmaceutical Preparations |x standards |z United States | |
650 | 4 | |a Pharmaceutical industry |x Quality control | |
650 | 4 | |a Quality Control |z United States | |
650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a GMP-Regeln |0 (DE-588)4113765-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Qualitätskontrolle |0 (DE-588)4047968-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Qualitätssicherung |0 (DE-588)4126457-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
651 | 4 | |a USA | |
651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 0 | 1 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
689 | 0 | 2 | |a Qualitätskontrolle |0 (DE-588)4047968-7 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 1 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 1 | 2 | |a Qualitätskontrolle |0 (DE-588)4047968-7 |D s |
689 | 1 | |8 2\p |5 DE-604 | |
689 | 2 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 2 | 1 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
689 | 2 | 2 | |a GMP-Regeln |0 (DE-588)4113765-6 |D s |
689 | 2 | |8 3\p |5 DE-604 | |
689 | 3 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 3 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
689 | 3 | 2 | |a GMP-Regeln |0 (DE-588)4113765-6 |D s |
689 | 3 | |8 4\p |5 DE-604 | |
689 | 4 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 4 | 1 | |a Qualitätssicherung |0 (DE-588)4126457-5 |D s |
689 | 4 | |8 5\p |5 DE-604 | |
689 | 5 | 0 | |a Qualitätskontrolle |0 (DE-588)4047968-7 |D s |
689 | 5 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
689 | 5 | |8 6\p |5 DE-604 | |
689 | 6 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
689 | 6 | 1 | |a Arzneimittelsicherheit |0 (DE-588)4143182-0 |D s |
689 | 6 | |8 7\p |5 DE-604 | |
700 | 1 | |a Tuckerman, Murray M. |e Verfasser |4 aut | |
700 | 1 | |a Hitchings, William S. |e Verfasser |4 aut | |
830 | 0 | |a Drugs and the pharmaceutical sciences. |v 2. |w (DE-604)BV000002008 |9 2 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-004802021 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 5\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 6\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 7\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804121679894413312 |
---|---|
any_adam_object | |
author | Willig, Sidney H. Tuckerman, Murray M. Hitchings, William S. |
author_facet | Willig, Sidney H. Tuckerman, Murray M. Hitchings, William S. |
author_role | aut aut aut |
author_sort | Willig, Sidney H. |
author_variant | s h w sh shw m m t mm mmt w s h ws wsh |
building | Verbundindex |
bvnumber | BV007417465 |
callnumber-first | Q - Science |
callnumber-label | QV771 W732G 1975 |
callnumber-raw | QV771 W732g 1975 RS189 |
callnumber-search | QV771 W732g 1975 RS189 |
callnumber-sort | QV 3771 W732 G 41975 |
classification_rvk | VX 5500 |
ctrlnum | (OCoLC)1959391 (DE-599)BVBBV007417465 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Chemie / Pharmazie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03890nam a2200925 cb4500</leader><controlfield tag="001">BV007417465</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1975 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1959391</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007417465</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QV771 W732g 1975</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS189</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 5500</subfield><subfield code="0">(DE-625)147800:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Willig, Sidney H.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Good manufacturing practices for pharmaceuticals</subfield><subfield code="b">A plan for total quality control</subfield><subfield code="c">Sidney H. Willig ; Murray M. Tuckerman ; William S. Hitchings*</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Dekker</subfield><subfield code="c">1975</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 167 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs and the pharmaceutical sciences.</subfield><subfield code="v">2.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - Qualité - Contrôle</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Normes - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Preparations</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Quality control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quality Control</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">GMP-Regeln</subfield><subfield code="0">(DE-588)4113765-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Qualitätskontrolle</subfield><subfield code="0">(DE-588)4047968-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Qualitätssicherung</subfield><subfield code="0">(DE-588)4126457-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Qualitätskontrolle</subfield><subfield code="0">(DE-588)4047968-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Qualitätskontrolle</subfield><subfield code="0">(DE-588)4047968-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">GMP-Regeln</subfield><subfield code="0">(DE-588)4113765-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">GMP-Regeln</subfield><subfield code="0">(DE-588)4113765-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Qualitätssicherung</subfield><subfield code="0">(DE-588)4126457-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="8">5\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="5" ind2="0"><subfield code="a">Qualitätskontrolle</subfield><subfield code="0">(DE-588)4047968-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2=" "><subfield code="8">6\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="6" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="6" ind2="1"><subfield code="a">Arzneimittelsicherheit</subfield><subfield code="0">(DE-588)4143182-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="6" ind2=" "><subfield code="8">7\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tuckerman, Murray M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hitchings, William S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drugs and the pharmaceutical sciences.</subfield><subfield code="v">2.</subfield><subfield code="w">(DE-604)BV000002008</subfield><subfield code="9">2</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004802021</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">6\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">7\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
geographic | USA USA (DE-588)4078704-7 gnd |
geographic_facet | USA |
id | DE-604.BV007417465 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T17:01:49Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004802021 |
oclc_num | 1959391 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-188 |
owner_facet | DE-355 DE-BY-UBR DE-188 |
physical | X, 167 S. |
publishDate | 1975 |
publishDateSearch | 1975 |
publishDateSort | 1975 |
publisher | Dekker |
record_format | marc |
series | Drugs and the pharmaceutical sciences. |
series2 | Drugs and the pharmaceutical sciences. |
spelling | Willig, Sidney H. Verfasser aut Good manufacturing practices for pharmaceuticals A plan for total quality control Sidney H. Willig ; Murray M. Tuckerman ; William S. Hitchings* New York Dekker 1975 X, 167 S. txt rdacontent n rdamedia nc rdacarrier Drugs and the pharmaceutical sciences. 2. Industrie pharmaceutique - Qualité - Contrôle Médicaments - Normes - États-Unis Drug Industry standards United States Drugs Standards United States Legislation, Drug United States Pharmaceutical Preparations standards United States Pharmaceutical industry Quality control Quality Control United States Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf GMP-Regeln (DE-588)4113765-6 gnd rswk-swf Arzneimittelsicherheit (DE-588)4143182-0 gnd rswk-swf Qualitätskontrolle (DE-588)4047968-7 gnd rswk-swf Qualitätssicherung (DE-588)4126457-5 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Pharmazeutische Technologie (DE-588)4045699-7 s Qualitätskontrolle (DE-588)4047968-7 s 1\p DE-604 Arzneimittel (DE-588)4003115-9 s 2\p DE-604 GMP-Regeln (DE-588)4113765-6 s 3\p DE-604 Pharmazeutische Industrie (DE-588)4045696-1 s 4\p DE-604 Qualitätssicherung (DE-588)4126457-5 s 5\p DE-604 6\p DE-604 Arzneimittelsicherheit (DE-588)4143182-0 s 7\p DE-604 Tuckerman, Murray M. Verfasser aut Hitchings, William S. Verfasser aut Drugs and the pharmaceutical sciences. 2. (DE-604)BV000002008 2 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 5\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 6\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 7\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Willig, Sidney H. Tuckerman, Murray M. Hitchings, William S. Good manufacturing practices for pharmaceuticals A plan for total quality control Drugs and the pharmaceutical sciences. Industrie pharmaceutique - Qualité - Contrôle Médicaments - Normes - États-Unis Drug Industry standards United States Drugs Standards United States Legislation, Drug United States Pharmaceutical Preparations standards United States Pharmaceutical industry Quality control Quality Control United States Pharmazeutische Technologie (DE-588)4045699-7 gnd GMP-Regeln (DE-588)4113765-6 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd Qualitätskontrolle (DE-588)4047968-7 gnd Qualitätssicherung (DE-588)4126457-5 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Arzneimittel (DE-588)4003115-9 gnd |
subject_GND | (DE-588)4045699-7 (DE-588)4113765-6 (DE-588)4143182-0 (DE-588)4047968-7 (DE-588)4126457-5 (DE-588)4045696-1 (DE-588)4003115-9 (DE-588)4078704-7 |
title | Good manufacturing practices for pharmaceuticals A plan for total quality control |
title_auth | Good manufacturing practices for pharmaceuticals A plan for total quality control |
title_exact_search | Good manufacturing practices for pharmaceuticals A plan for total quality control |
title_full | Good manufacturing practices for pharmaceuticals A plan for total quality control Sidney H. Willig ; Murray M. Tuckerman ; William S. Hitchings* |
title_fullStr | Good manufacturing practices for pharmaceuticals A plan for total quality control Sidney H. Willig ; Murray M. Tuckerman ; William S. Hitchings* |
title_full_unstemmed | Good manufacturing practices for pharmaceuticals A plan for total quality control Sidney H. Willig ; Murray M. Tuckerman ; William S. Hitchings* |
title_short | Good manufacturing practices for pharmaceuticals |
title_sort | good manufacturing practices for pharmaceuticals a plan for total quality control |
title_sub | A plan for total quality control |
topic | Industrie pharmaceutique - Qualité - Contrôle Médicaments - Normes - États-Unis Drug Industry standards United States Drugs Standards United States Legislation, Drug United States Pharmaceutical Preparations standards United States Pharmaceutical industry Quality control Quality Control United States Pharmazeutische Technologie (DE-588)4045699-7 gnd GMP-Regeln (DE-588)4113765-6 gnd Arzneimittelsicherheit (DE-588)4143182-0 gnd Qualitätskontrolle (DE-588)4047968-7 gnd Qualitätssicherung (DE-588)4126457-5 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Arzneimittel (DE-588)4003115-9 gnd |
topic_facet | Industrie pharmaceutique - Qualité - Contrôle Médicaments - Normes - États-Unis Drug Industry standards United States Drugs Standards United States Legislation, Drug United States Pharmaceutical Preparations standards United States Pharmaceutical industry Quality control Quality Control United States Pharmazeutische Technologie GMP-Regeln Arzneimittelsicherheit Qualitätskontrolle Qualitätssicherung Pharmazeutische Industrie Arzneimittel USA |
volume_link | (DE-604)BV000002008 |
work_keys_str_mv | AT willigsidneyh goodmanufacturingpracticesforpharmaceuticalsaplanfortotalqualitycontrol AT tuckermanmurraym goodmanufacturingpracticesforpharmaceuticalsaplanfortotalqualitycontrol AT hitchingswilliams goodmanufacturingpracticesforpharmaceuticalsaplanfortotalqualitycontrol |